Chronic Myeloid Leukemia Treatment Discontinuation

0 Views
administrator
administrator
06/27/23

The panelists, Jorge Cortes, MD; Kevin Kelly, MD, PhD; David Snyder, MD, FACP; Harry Erba, MD, PhD; and Javier Pinilla-Ibarz, MD, PhD, discuss under what conditions treatment discontinuation may be considered in the management of chronic myeloid leukemia.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next